BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 37063298)

  • 1. Rev-erbα agonist SR9009 protects against cerebral ischemic injury through mechanisms involving Nrf2 pathway.
    Sheng M; Chen X; Yu Y; Wu Q; Kou J; Chen G
    Front Pharmacol; 2023; 14():1102567. PubMed ID: 37063298
    [No Abstract]   [Full Text] [Related]  

  • 2. Ruscogenin timing administration mitigates cerebral ischemia-reperfusion injury through regulating circadian genes and activating Nrf2 pathway.
    Zhang S; Yu Y; Sheng M; Chen X; Wu Q; Kou J; Chen G
    Phytomedicine; 2023 Nov; 120():155028. PubMed ID: 37659295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting Rev-Erbα to protect against ischemia-reperfusion-induced acute lung injury in rats.
    Chu SJ; Liao WI; Pao HP; Wu SY; Tang SE
    Respir Res; 2023 Oct; 24(1):247. PubMed ID: 37828537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remote ischemic conditioning attenuates oxidative stress and inflammation via the Nrf2/HO-1 pathway in MCAO mice.
    Sun YY; Zhu HJ; Zhao RY; Zhou SY; Wang MQ; Yang Y; Guo ZN
    Redox Biol; 2023 Oct; 66():102852. PubMed ID: 37598463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circadian Rhythm Regulator REV-ERBα Attenuates Neuroapoptosis in Early Brain Injury After Experimental Subarachnoid Hemorrhage in Rats.
    Lu Z; Shen H; Li X; Li H; You W; Wang Z; Chen G
    Neurochem Res; 2023 Jun; 48(6):1925-1944. PubMed ID: 36757575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. REV-ERBα agonist SR9009 suppresses IL-1β production in macrophages through BMAL1-dependent inhibition of inflammasome.
    Hong H; Cheung YM; Cao X; Wu Y; Li C; Tian XY
    Biochem Pharmacol; 2021 Oct; 192():114701. PubMed ID: 34324866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rev-erbα regulates hepatic ischemia-reperfusion injury in mice.
    Lin Y; Lin L; Gao L; Wang S; Wu B
    Biochem Biophys Res Commun; 2020 Sep; 529(4):916-921. PubMed ID: 32819599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mechanism of gypenoside XVII against cerebral ischemia/reperfusion injury based on nuclear factor erythroid 2-related factor 2/antioxidant responsive element signaling pathway].
    Wang W; Xu Y; Xu S; Mao L
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Mar; 35(3):293-298. PubMed ID: 36916343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SR9009 Regulates Acute Lung Injury in Mice Induced by Sepsis.
    Hu M; Zhang L; Cao J; Jiang Y; Liu G
    Can Respir J; 2022; 2022():5802938. PubMed ID: 35814267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eriocitrin alleviates oxidative stress and inflammatory response in cerebral ischemia reperfusion rats by regulating phosphorylation levels of Nrf2/NQO-1/HO-1/NF-κB p65 proteins.
    He J; Zhou D; Yan B
    Ann Transl Med; 2020 Jun; 8(12):757. PubMed ID: 32647682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The circadian clock protein Rev-erbα provides neuroprotection and attenuates neuroinflammation against Parkinson's disease via the microglial NLRP3 inflammasome.
    Kou L; Chi X; Sun Y; Han C; Wan F; Hu J; Yin S; Wu J; Li Y; Zhou Q; Zou W; Xiong N; Huang J; Xia Y; Wang T
    J Neuroinflammation; 2022 Jun; 19(1):133. PubMed ID: 35668454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resveratrol pretreatment attenuates cerebral ischemic injury by upregulating expression of transcription factor Nrf2 and HO-1 in rats.
    Ren J; Fan C; Chen N; Huang J; Yang Q
    Neurochem Res; 2011 Dec; 36(12):2352-62. PubMed ID: 21850487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SR9009 induces a REV-ERB dependent anti-small-cell lung cancer effect through inhibition of autophagy.
    Shen W; Zhang W; Ye W; Wang H; Zhang Q; Shen J; Hong Q; Li X; Wen G; Wei T; Zhang J
    Theranostics; 2020; 10(10):4466-4480. PubMed ID: 32292508
    [No Abstract]   [Full Text] [Related]  

  • 14. Bicyclol upregulates transcription factor Nrf2, HO-1 expression and protects rat brains against focal ischemia.
    Zhang J; Fu B; Zhang X; Zhang L; Bai X; Zhao X; Chen L; Cui L; Zhu C; Wang L; Zhao Y; Zhao T; Wang X
    Brain Res Bull; 2014 Jan; 100():38-43. PubMed ID: 24252362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circadian Clock REV-ERBs Agonist SR9009 Induces Synergistic Antitumor Activity in Multiple Myeloma by Suppressing Glucose-Regulated Protein 78-Dependent Autophagy and Lipogenesis.
    Wang R; Liu SL; Guo QQ; Shi XH; Ma MM
    World J Oncol; 2023 Dec; 14(6):464-475. PubMed ID: 38022411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of SIRT1 regulating Nrf2/HO-1 signaling pathway on sepsis-induced acute lung injury].
    Zhang Y; Chen M; Wang Y; Li X; Yu X
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Mar; 35(3):244-249. PubMed ID: 36916335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of Rev-erbα attenuates lipopolysaccharide-induced inflammatory reactions in human endometrial stroma cells via suppressing TLR4-regulated NF-κB activation.
    Zhao W; Cui L; Huang X; Wang S; Li D; Li L; Sun Y; Du M
    Acta Biochim Biophys Sin (Shanghai); 2019 Sep; 51(9):908-914. PubMed ID: 31411318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Huang-Lian-Jie-Du-Decotion induced protective autophagy against the injury of cerebral ischemia/reperfusion via MAPK-mTOR signaling pathway.
    Wang PR; Wang JS; Zhang C; Song XF; Tian N; Kong LY
    J Ethnopharmacol; 2013 Aug; 149(1):270-80. PubMed ID: 23811213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Posttreatment with 11-Keto-β-Boswellic Acid Ameliorates Cerebral Ischemia-Reperfusion Injury: Nrf2/HO-1 Pathway as a Potential Mechanism.
    Ding Y; Chen M; Wang M; Li Y; Wen A
    Mol Neurobiol; 2015 Dec; 52(3):1430-1439. PubMed ID: 25452227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-6 deletion decreased REV-ERBα protein and influenced autophagy and mitochondrial markers in the skeletal muscle after acute exercise.
    Pinto AP; Muñoz VR; da Rocha AL; Rovina RL; Ferrari GD; Alberici LC; Simabuco FM; Teixeira GR; Pauli JR; de Moura LP; Cintra DE; Ropelle ER; Freitas EC; Rivas DA; da Silva ASR
    Front Immunol; 2022; 13():953272. PubMed ID: 36311768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.